Welcome to LookChem.com Sign In|Join Free
  • or
1-(3,4-dichlorophenyl)cyclohexanecarbonyl chloride is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

162733-01-9

Post Buying Request

162733-01-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

162733-01-9 Usage

Reactivity

Highly reactive

Toxicity

Toxic

Usage

Intermediate in the synthesis of pharmaceuticals and agrochemicals

Hazardous

Yes, should be handled with extreme caution

Physical state

Colorless to pale yellow liquid

Odor

Pungent

Solubility

Highly soluble in organic solvents

Applications

Production of drugs, pesticides, and as a reagent in organic synthesis

Role in synthesis

Key intermediate in the synthesis of cyclohexanecarboxylic acid derivatives

Check Digit Verification of cas no

The CAS Registry Mumber 162733-01-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,2,7,3 and 3 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 162733-01:
(8*1)+(7*6)+(6*2)+(5*7)+(4*3)+(3*3)+(2*0)+(1*1)=119
119 % 10 = 9
So 162733-01-9 is a valid CAS Registry Number.

162733-01-9Downstream Products

162733-01-9Relevant academic research and scientific papers

Novel 1-Phenylcycloalkanecarboxylic Acid Derivatives Are Potent and Selective ?1 Ligands

Calderon, Silvia N.,Izenwasser, Sari,Heller, Brett,Gutkind, J. Silvio,Mattson, Mariena V.,et al.

, p. 2285 - 2291 (2007/10/02)

Carbetapentane (1, 2-ethyl 1-phenyl-1-cyclopentanecarboxylate) binds with high affinity to ? sites and is a potent antitussive, anticonvulsant, and spasmolytic agent.However, carbetapentane interacts at muscarinic binding sites as well, and it is not clear whether either of these receptor systems is involved in the mechanism(s) of action(s) of this drug.In an attempt to determine whether these psychoactivities can be attributed to interaction at ? sites, a series of carbetapentane analogs were prepared.Phenyl ring substitution; contraction expansion, and replacement with a methyl group of the cyclopentyl ring; replacement of the carboxylate function with an amide, methyl ether, and methylamine; and replacement of the N,N-diethyl substituent with a morpholino or piperidino moiety were investigated.All of these novel analogs were evaluated for binding to ?1 and ?2 sites, and comparison of binding at muscarinic m1 and m2 and PCP (1-(1-phenylcyclohexyl)piperidine) receptors was performed.All of the compounds were selective for ?1 over ?2 sites, with the three most selective analogs being compounds 34 (65-fold), 35 (78-fold), and 39 (51-fold).None of the compounds were active at PCP sites, and chemical modification including (1) replacing the ester function, (2) replacing the cyclopentyl ring with a smaller ring system (cyclopropyl) or a methyl group, and (3) replacing the diethylamino moiety with a morpholino group resulted in >220-fold selectivity over muscarinic receptor binding.Therefore, several of these novel compounds are potent, ?1-selective ligands which can now be investigated as potential antitussive, anticonvulsant, and antiischemic agents.These studies may reveal whether ?1 sites play a role in the pharmacological actions of these drugs.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 162733-01-9